U2AF1 and other splicing factor gene mutations in telomere biology disorders are associated with hematologic neoplasia and worse overall survival (2021)
- Authors:
- Autor USP: RODRIGUES, RODRIGO DO TOCANTINS CALADO DE SALOMA - FMRP
- Unidade: FMRP
- DOI: 10.1182/blood-2021-146946
- Subjects: MUTAÇÃO GENÉTICA; NEOPLASIAS; SANGUE; TELÔMERO; MEDULA ÓSSEA
- Language: Inglês
- Imprenta:
- Publisher place: Washington
- Date published: 2021
- Source:
- Conference titles: ASH Annual Meeting Abstracts
- Este periódico é de assinatura
- Este artigo é de acesso aberto
- URL de acesso aberto
- Cor do Acesso Aberto: bronze
-
ABNT
GROARKE, Emma M. et al. U2AF1 and other splicing factor gene mutations in telomere biology disorders are associated with hematologic neoplasia and worse overall survival. Blood. Washington: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. Disponível em: https://doi.org/10.1182/blood-2021-146946. Acesso em: 02 jan. 2026. , 2021 -
APA
Groarke, E. M., Gutierrez-Rodrigues, F., Ma, X., Patel, B. A., Spitofsky, N., Browne, P. V., et al. (2021). U2AF1 and other splicing factor gene mutations in telomere biology disorders are associated with hematologic neoplasia and worse overall survival. Blood. Washington: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. doi:10.1182/blood-2021-146946 -
NLM
Groarke EM, Gutierrez-Rodrigues F, Ma X, Patel BA, Spitofsky N, Browne PV, Chien KS, Wu CO, DiNardo CD, Colla S, Calado RT, Young NS. U2AF1 and other splicing factor gene mutations in telomere biology disorders are associated with hematologic neoplasia and worse overall survival [Internet]. Blood. 2021 ; 138 862-864.[citado 2026 jan. 02 ] Available from: https://doi.org/10.1182/blood-2021-146946 -
Vancouver
Groarke EM, Gutierrez-Rodrigues F, Ma X, Patel BA, Spitofsky N, Browne PV, Chien KS, Wu CO, DiNardo CD, Colla S, Calado RT, Young NS. U2AF1 and other splicing factor gene mutations in telomere biology disorders are associated with hematologic neoplasia and worse overall survival [Internet]. Blood. 2021 ; 138 862-864.[citado 2026 jan. 02 ] Available from: https://doi.org/10.1182/blood-2021-146946 - Androgen treatment mitigates hematopoietic cell telomere attrition in vivo
- Age-adjusted recipient pretransplantation telomere length and treatment-related mortality after hematopoietic stem cell transplantation
- Telomeres in disease
- Células reprogramadas. [Depoimento a Hérika Dias e Luis Ribeiro]
- Telomere shortening in hepatocyte proliferation and predisposition to alcohol-induced steatosis
- Efficacy and safety of eltrombopag combined with cyclosporine as first-line therapy in adults with severe acquired aplastic anemia: results of the interventional phase 2 single-arm soar study
- Molecular characterization of clinical response and relapse in patients with IDH1m ND-AML treated with Ivo+AZA in the aGILE study
- BCL2A1a over-expression in murine hematopoietic stem and progenitor cells decreases apoptosis and results in hematopoietic transformation
- GATA2 mutation in long stand Mycobacterium kansasii infection, myelodysplasia and MonoMAC syndrome: a case-report
- A novel homozygous RTEL1 variant in a consanguineous Lebanese family: phenotypic heterogeneity and disease anticipation
Informações sobre o DOI: 10.1182/blood-2021-146946 (Fonte: oaDOI API)
Download do texto completo
| Tipo | Nome | Link | |
|---|---|---|---|
 |
003237495.pdf |
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
